This study is monitoring the long-term safety and effectiveness of the drug vamorolone in boys with Duchenne muscular dystrophy (DMD). It includes 80 boys who have already been taking vamorolone through special access programs. The main goal is to check for side effects like bone…
Phase: PHASE4 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC